Therapeutic efficacy of herbal extracts on a model for triple negative breast cancer

被引：0
|
作者：
Telang, Nitin [1 ]
机构：
[1] Palindrome Liaisons Consultants, Canc Prevent Res Program, Montvale, NJ USA
来源：
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE | 2015年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
117
引用
收藏
页码：S9 / S9
页数：1
相关论文
共 50 条
  • [41] Efficacy of Neoadjuvant Cisplatin in Triple-Negative Breast Cancer
    Silver, Daniel P.
    Richardson, Andrea L.
    Eklund, Aron C.
    Wang, Zhigang C.
    Szallasi, Zoltan
    Li, Qiyuan
    Juul, Nicolai
    Leong, Chee-Onn
    Calogrias, Diana
    Buraimoh, Ayodele
    Fatima, Aquila
    Gelman, Rebecca S.
    Ryan, Paula D.
    Tung, Nadine M.
    De Nicolo, Arcangela
    Ganesan, Shridar
    Miron, Alexander
    Colin, Christian
    Sgroi, Dennis C.
    Ellisen, Leif W.
    Winer, Eric P.
    Garber, Judy E.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (07) : 1145 - 1153
  • [42] The efficacy of betulinic acid in triple-negative breast cancer
    Weber, Daniel
    Zhang, Mixia
    Zhuang, Pengwei
    Zhang, Yanjun
    Wheat, Janelle
    Currie, Geoffrey
    Al-Eisawi, Zaynab
    SAGE OPEN MEDICINE, 2014, 2
  • [43] An In Vitro Model of Triple-Negative Breast Cancer
    Russo, J.
    Su, Y.
    HUMAN CELL TRANSFORMATION: ADVANCES IN CELL MODELS FOR THE STUDY OF CANCER AND AGING, 2019, 1164 : 35 - 46
  • [44] Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
    Cheng, Robert Y. S.
    Patel, Nimit L.
    Back, Timothy
    Basudhar, Debashree
    Somasundaram, Veena
    Kalen, Joseph D.
    Wink, David A.
    Ridnour, Lisa A.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2020, (157):
  • [45] Therapeutic efficacy and mechanism of CD73-TGFβ dual-blockade in a mouse model of triple-negative breast cancer
    Xing, Yun
    Ren, Zhi-qiang
    Jin, Rui
    Liu, Liang
    Pei, Jin-peng
    Yu, Ker
    ACTA PHARMACOLOGICA SINICA, 2022, 43 (09) : 2410 - 2418
  • [46] Therapeutic efficacy and mechanism of CD73-TGFβ dual-blockade in a mouse model of triple-negative breast cancer
    Yun Xing
    Zhi-qiang Ren
    Rui Jin
    Liang Liu
    Jin-peng Pei
    Ker Yu
    Acta Pharmacologica Sinica, 2022, 43 : 2410 - 2418
  • [47] cMET in triple-negative breast cancer: is it a therapeutic target for this subset of breast cancer patients?
    Gaule, Patricia B.
    Crown, John
    O'Donovan, Norma
    Duffy, Michael J.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2014, 18 (09) : 999 - 1009
  • [48] Radiotherapy improves efficacy of the PARP inhibitor Niraparib in a preclinical model of triple negative breast cancer
    Binder, P.
    Katopodi, T.
    Hanson, L.
    Bell, C.
    Flanagan, E.
    Farrington, P.
    Moore, N.
    Wright, E.
    Bunday, T.
    Brown, S.
    Cantrell, A.
    Greenall, J.
    Sharman, S.
    Woolley, J.
    Mooney, L.
    Kendrew, J.
    EUROPEAN JOURNAL OF CANCER, 2024, 211 : S125 - S125
  • [49] Efficacy of a leptin receptor antagonist peptide in a mouse model of triple-negative breast cancer
    Otvos, Laszlo, Jr.
    Kovalszky, Ilona
    Riolfi, Mirko
    Ferla, Rita
    Olah, Julia
    Sztodola, Andras
    Nama, Kaushik
    Molino, Annamaria
    Piubello, Quirino
    Wade, John D.
    Surmacz, Eva
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (10) : 1578 - 1584
  • [50] Growth Inhibitory Efficacy of Chinese Herbs in a Cellular Model for Triple-Negative Breast Cancer
    Telang, Nitin T.
    Nair, Hareesh B.
    Wong, George Y. C.
    PHARMACEUTICALS, 2021, 14 (12)
12345